Our study is unique as we characterized IRF1 expression in all cell types in breast tissue of HER2+ patients in contrast to previous studies that have utilized breast bulk patient samples in toto or tumor epithelial cell lines. The gene discussed is ERBB2; the disease is neoplasm.